Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical leader engaged in the discovery, development, manufacture, and sale of medicines. It operates facilities in the United States, Puerto Rico, and many other countries, with products sold in about 135 countries. The company focuses on therapies in neuroscience, cardiometabolic, cancer, and immunology, and also conducts research in animal health and animal agriculture. Lilly supports patient outcomes and education through a philanthropic foundation that funds programs in underserved communities, including STEM education in Indianapolis.

Gordon Brooks

Steve Hall

Venture Partner

Judith Li

Partner

Jiaxin Li

Partner

Armen Shanafelt Ph.D

Venture Partner

S. Edward Torres

Managing Director

Past deals in Wales

Aparito

Acquisition in 2024
Aparito Limited is a health technology company based in Wrexham, United Kingdom, focused on digitizing clinical trials and enhancing drug development processes. Established in 2014, the company develops mobile applications and wearable devices that facilitate real-time patient monitoring outside of traditional healthcare settings. Its Atom5™ platform supports patient-centric clinical trials by capturing frequent patient-generated data through various methods, including video eCOAs, ePROs, wearables, and telemedicine. This innovative approach allows for continuous data collection, improving understanding of diseases and clinical trial outcomes while ensuring compliance with relevant regulations. By enabling patients and their caregivers to participate in research from home, Aparito aims to improve patient outcomes and streamline the drug development process.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.